Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second

Jin Hyo Kim; Sung Soo Park; Jae Ho Yoon; Sung Eun Lee; Hee Je Kim; Chang Ki Min

doi:10.5045/br.2022.2021183

Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second

Department of Internal Medicine

Catholic Univ. of Korea Coll. Med.

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	76-80
Number of pages	5
Journal	Blood Research
Volume	57
Issue number	1
DOIs	https://doi.org/10.5045/br.2022.2021183
State	Published - 2022

Bibliographical note

Funding Information:
J.H.K. analyzed the data and wrote the paper. J.H.Y. and S.E.L. contributed to the acquisition of the data. H.J.K. and C.K.M contributed to the conception of the study. S.S.P. designed the study. The drafted manuscript was reviewed by all authors. The authors acknowledge all members at the Catholic Hematology Hospital, particularly the house staff, for their excellent care of the patients.

Access to Document

10.5045/br.2022.2021183

Cite this

@article{7a449a8a47304602b754593ca15af283,

title = "Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second",

author = "Kim, \{Jin Hyo\} and Park, \{Sung Soo\} and Yoon, \{Jae Ho\} and Lee, \{Sung Eun\} and Kim, \{Hee Je\} and Min, \{Chang Ki\}",

note = "Funding Information: J.H.K. analyzed the data and wrote the paper. J.H.Y. and S.E.L. contributed to the acquisition of the data. H.J.K. and C.K.M contributed to the conception of the study. S.S.P. designed the study. The drafted manuscript was reviewed by all authors. The authors acknowledge all members at the Catholic Hematology Hospital, particularly the house staff, for their excellent care of the patients.",

year = "2022",

doi = "10.5045/br.2022.2021183",

language = "English",

volume = "57",

pages = "76--80",

journal = "Blood Research",

issn = "2287-979X",

publisher = "Springer",

number = "1",

}

TY - JOUR

T1 - Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second

AU - Kim, Jin Hyo

AU - Park, Sung Soo

AU - Yoon, Jae Ho

AU - Lee, Sung Eun

AU - Kim, Hee Je

AU - Min, Chang Ki

N1 - Funding Information: J.H.K. analyzed the data and wrote the paper. J.H.Y. and S.E.L. contributed to the acquisition of the data. H.J.K. and C.K.M contributed to the conception of the study. S.S.P. designed the study. The drafted manuscript was reviewed by all authors. The authors acknowledge all members at the Catholic Hematology Hospital, particularly the house staff, for their excellent care of the patients.

PY - 2022

Y1 - 2022

UR - https://www.scopus.com/pages/publications/85128775980

U2 - 10.5045/br.2022.2021183

DO - 10.5045/br.2022.2021183

M3 - Letter

AN - SCOPUS:85128775980

SN - 2287-979X

VL - 57

SP - 76

EP - 80

JO - Blood Research

JF - Blood Research

IS - 1

ER -

Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second

Bibliographical note

Access to Document

Other files and links

Cite this